Authors
Loading...
Formulation demonstrates enhanced drug delivery in patients with Alzheimer's and Parkinson's diseases, indicating better compliance.
Nakat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: